Literature DB >> 25907374

Potential risk of misclassification HCV 2k/1b strains as HCV 2a/2c using VERSANT HCV Genotype 2.0 assay.

Steven De Keukeleire1, Patrick Descheemaeker2, Marijke Reynders2.   

Abstract

The performance of a hepatitis C virus (HCV) NS5B sequencing method described by Murphy et al. (Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol 2007;45(4):1102-12.) was compared with the VERSANT HCV Genotype 2.0 assay. The sequencing strategy led to detection of HCV recombinant genotype 2k/1b, previously identified as genotype 2a/2c, which reveals the importance of exact HCV genotyping and subtyping.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HCV 2k/1b; HCV genotyping and subtyping; Hepatitis C virus; Recombinant forms

Mesh:

Year:  2015        PMID: 25907374     DOI: 10.1016/j.diagmicrobio.2015.04.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

Review 1.  Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C.

Authors:  Eleanor M Wilson; Elana S Rosenthal; Sarah Kattakuzhy; Lydia Tang; Shyam Kottilil
Journal:  Clin Microbiol Rev       Date:  2016-10-19       Impact factor: 26.132

2.  Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras.

Authors:  Johannes Vermehren; Christoph Sarrazin; Kai-Henrik Peiffer; Lisa Kuhnhenn; Evelyn Stelzl; Julia Dietz; Simone Susser; Andrea Oliver Tal; Fabian Finkelmeier; Eli Zuckerman; Marcus Cornberg; Mira Barak; Valeria Piazzolla; Alessandra Mangia; Stefan Zeuzem; Harald H Kessler
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

3.  Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.

Authors:  Wim Schuermans; Hans Orlent; Isabelle Desombere; Patrick Descheemaeker; Hans Van Vlierberghe; Anja Geerts; Xavier Verhelst; Marijke Reynders; Elizaveta Padalko
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.